Fundraising FoxRadical Investments — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Perlaraperlara.com𝕏Nov 2017
Perlara is a biopharmaceutical company that develops treatments for ultra-rare genetic diseases using yeast-based disease modeling and drug repurposing strategies.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Ethan Perlstein(CEO)in
BoardMatthew Wilsey(Director)Linda Avey(Director)
Co-investorsY CombinatorAgrolimen VenturesHaystackHomebrewLemonade CapitalMicroVentures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.